A-shares
600276
Public report available
Hengrui Pharmaceuticals
Chinese leader in innovative-drug R&D and commercialization
Why these companies
Selection basis
Representative companies
Innovative medicines leader list
A-shares
688235
Report not generated
BeOne Medicines
Global innovative-drug R&D and commercialization platform
A-shares
600196
Report not generated
Fosun Pharma
Innovative-drug and global healthcare platform
A-shares
002422
Report not generated
Kelun Pharmaceutical
Representative innovative-drug and ADC developer
Hong Kong stocks
01801
Report not generated
Innovent Biologics
Leading commercial-stage innovative biologics company
Hong Kong stocks
09926
Report not generated
Akeso
Representative bispecific-antibody developer with global licensing
A standard report for a new stock is free for the first generation. Professional valuation is paid and uses one credit. Existing public reports are free to view.
Sources
Industry and company sources
This page is a research directory. “Representative leader” is not an official designation, a return forecast or trading advice. Valuations and reports may contain errors or outdated information; verify against company filings and authoritative sources.